• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非酒精性脂肪性肝病中肝脏微小RNA表达异常

Aberrant hepatic microRNA expression in nonalcoholic fatty liver disease.

作者信息

Feng Yue Ying, Xu Xiao Qin, Ji Chen Bo, Shi Chun Mei, Guo Xi Rong, Fu Jun Fen

机构信息

Department of Endocrinology, the Children's Hospital of Zhejiang University School of Medicine, Hangzhou, China.

出版信息

Cell Physiol Biochem. 2014;34(6):1983-97. doi: 10.1159/000366394. Epub 2014 Nov 26.

DOI:10.1159/000366394
PMID:25562147
Abstract

BACKGROUND/AIM: Emerging evidence suggests that microRNA (miRNA) mediated gene regulation influences the maintenance of metabolic homeostasis, particularly the states of obesity and insulin resistance, thereby providing a potential link between miRNAs and nonalcoholic fatty liver disease (NAFLD).

METHODS

Sprague-Dawley rats fed a high-fat diet (HFD) were used to establish a rat model of NAFLD. The miRNA expression profile of liver tissues was evaluated using Illumina HiSeq deep sequencing. Selected miRNAs were then validated by real-time PCR at both 4- and 12-week time points. Furthermore, the expression levels of these miRNAs were assessed in HepG2 cells and human hepatocytes treated with free fatty acids (FFAs) and proinflammatory factors (tumour necrosis factor-alpha (TNF-α) and interleukin-6 (IL-6).

RESULTS

Our results showed that consumption of a HFD for 4 weeks caused simple steatosis, which progressed to steatohepatitis at 12 weeks. miRNA deep sequencing analysis identified 44 known up-regulated miRNAs (fold change >1.5) and 12 down-regulated miRNAs (fold change <0.5). Among the abnormally expressed miRNAs, miR-200a, miR-200b, miR-200c, miR-146a, miR-146b and miR-152 were up-regulated both in vitro and vivo. Interestingly, the expression levels of these six miRNAs were increased in HepG2 cells and human hepatocytes after treatment with FFAs and proinflammatory factors.

CONCLUSION

These findings suggest a critical role for miRNAs in the pathogenesis of NAFLD.

摘要

背景/目的:新出现的证据表明,微小RNA(miRNA)介导的基因调控影响代谢稳态的维持,尤其是肥胖和胰岛素抵抗状态,从而在miRNA与非酒精性脂肪性肝病(NAFLD)之间提供了潜在联系。

方法

使用喂食高脂饮食(HFD)的Sprague-Dawley大鼠建立NAFLD大鼠模型。使用Illumina HiSeq深度测序评估肝组织的miRNA表达谱。然后在4周和12周时间点通过实时PCR验证所选的miRNA。此外,在经游离脂肪酸(FFA)和促炎因子(肿瘤坏死因子-α(TNF-α)和白细胞介素-6(IL-6))处理的HepG2细胞和人肝细胞中评估这些miRNA的表达水平。

结果

我们的结果表明,食用4周HFD会导致单纯性脂肪变性,在12周时进展为脂肪性肝炎。miRNA深度测序分析鉴定出44个已知的上调miRNA(倍数变化>1.5)和12个下调miRNA(倍数变化<0.5)。在异常表达的miRNA中,miR-200a、miR-200b、miR-200c、miR-146a、miR-146b和miR-152在体外和体内均上调。有趣的是,在用FFA和促炎因子处理后,HepG2细胞和人肝细胞中这六种miRNA的表达水平升高。

结论

这些发现表明miRNA在NAFLD发病机制中起关键作用。

相似文献

1
Aberrant hepatic microRNA expression in nonalcoholic fatty liver disease.非酒精性脂肪性肝病中肝脏微小RNA表达异常
Cell Physiol Biochem. 2014;34(6):1983-97. doi: 10.1159/000366394. Epub 2014 Nov 26.
2
Downregulation of microRNA-451 in non-alcoholic steatohepatitis inhibits fatty acid-induced proinflammatory cytokine production through the AMPK/AKT pathway.非酒精性脂肪性肝炎中微小RNA-451的下调通过AMPK/AKT途径抑制脂肪酸诱导的促炎细胞因子产生。
Int J Biochem Cell Biol. 2015 Jul;64:265-76. doi: 10.1016/j.biocel.2015.04.016. Epub 2015 May 7.
3
Downregulated microRNA-130b-5p prevents lipid accumulation and insulin resistance in a murine model of nonalcoholic fatty liver disease.下调 microRNA-130b-5p 可预防非酒精性脂肪性肝病小鼠模型中的脂质积累和胰岛素抵抗。
Am J Physiol Endocrinol Metab. 2020 Jul 1;319(1):E34-E42. doi: 10.1152/ajpendo.00528.2019. Epub 2020 Mar 31.
4
Chaihu Shugan powder influences nonalcoholic fatty liver disease in rats in remodeling microRNAome and decreasing fatty acid synthesis.柴胡疏肝散通过重塑微小RNA组和减少脂肪酸合成来影响大鼠非酒精性脂肪性肝病。
J Ethnopharmacol. 2024 Jan 10;318(Pt A):116967. doi: 10.1016/j.jep.2023.116967. Epub 2023 Jul 26.
5
Intracellular and extracellular miRNome deregulation in cellular models of NAFLD or NASH: Clinical implications.非酒精性脂肪性肝病(NAFLD)或非酒精性脂肪性肝炎(NASH)细胞模型中细胞内和细胞外微小RNA组失调:临床意义
Nutr Metab Cardiovasc Dis. 2016 Dec;26(12):1129-1139. doi: 10.1016/j.numecd.2016.08.004. Epub 2016 Aug 20.
6
MicroRNA-194 inhibition improves dietary-induced non-alcoholic fatty liver disease in mice through targeting on FXR.miR-194 抑制通过靶向 FXR 改善饮食诱导的小鼠非酒精性脂肪性肝病。
Biochim Biophys Acta Mol Basis Dis. 2017 Dec;1863(12):3087-3094. doi: 10.1016/j.bbadis.2017.09.020. Epub 2017 Sep 22.
7
Novel hepatic microRNAs upregulated in human nonalcoholic fatty liver disease.在人类非酒精性脂肪性肝病中上调的新型肝脏微小RNA。
Physiol Rep. 2016 Jan;4(1). doi: 10.14814/phy2.12661.
8
Decreased lipid metabolism but increased FA biosynthesis are coupled with changes in liver microRNAs in obese subjects with NAFLD.在患有非酒精性脂肪性肝病(NAFLD)的肥胖受试者中,脂质代谢降低但脂肪酸生物合成增加与肝脏微小RNA的变化相关。
Int J Obes (Lond). 2017 Apr;41(4):620-630. doi: 10.1038/ijo.2017.21. Epub 2017 Jan 25.
9
MicroRNA-122 Inhibits Lipid Droplet Formation and Hepatic Triglyceride Accumulation via Yin Yang 1.微小RNA-122通过阴阳1抑制脂滴形成和肝脏甘油三酯蓄积。
Cell Physiol Biochem. 2017;44(4):1651-1664. doi: 10.1159/000485765. Epub 2017 Dec 6.
10
miR-212 downregulation contributes to the protective effect of exercise against non-alcoholic fatty liver via targeting FGF-21.miR-212的下调通过靶向FGF-21促进运动对非酒精性脂肪肝的保护作用。
J Cell Mol Med. 2016 Feb;20(2):204-16. doi: 10.1111/jcmm.12733. Epub 2015 Dec 9.

引用本文的文献

1
Role of microRNAs in Osteosarcopenic Obesity/Adiposity: A Scoping Review.微小RNA在骨质疏松性肥胖/脂肪过多症中的作用:一项范围综述
Cells. 2025 May 29;14(11):802. doi: 10.3390/cells14110802.
2
Two sides of the same coin: Non-alcoholic fatty liver disease and atherosclerosis.同一枚硬币的两面:非酒精性脂肪性肝病与动脉粥样硬化。
Vascul Pharmacol. 2024 Mar;154:107249. doi: 10.1016/j.vph.2023.107249. Epub 2023 Dec 7.
3
Diagnostic potential of miR-200 family members in gingival crevicular fluid for chronic periodontitis: correlation with clinical parameters and therapeutic implications.
miR-200 家族成员在龈沟液中用于慢性牙周炎的诊断潜力:与临床参数的相关性及其治疗意义。
BMC Oral Health. 2023 Jul 31;23(1):532. doi: 10.1186/s12903-023-03174-w.
4
Bioactive Compounds as Inhibitors of Inflammation, Oxidative Stress and Metabolic Dysfunctions via Regulation of Cellular Redox Balance and Histone Acetylation State.生物活性化合物通过调节细胞氧化还原平衡和组蛋白乙酰化状态作为炎症、氧化应激和代谢功能障碍的抑制剂。
Foods. 2023 Feb 22;12(5):925. doi: 10.3390/foods12050925.
5
Exploring the Regulatory Role of ncRNA in NAFLD: A Particular Focus on PPARs.探讨非编码 RNA 在非酒精性脂肪性肝病中的调控作用:特别关注过氧化物酶体增殖物激活受体。
Cells. 2022 Dec 7;11(24):3959. doi: 10.3390/cells11243959.
6
Circulating mir-200c and mir-33a may be used as biomarkers for predicting high fructose corn syrup-induced fatty liver and vitamin D supplementation-related liver changes.循环 mir-200c 和 mir-33a 可作为预测高果糖玉米糖浆诱导的脂肪肝和维生素 D 补充相关肝脏变化的生物标志物。
Turk J Med Sci. 2022 Oct;52(5):1448-1457. doi: 10.55730/1300-0144.5483. Epub 2022 Oct 19.
7
Rosavin Ameliorates Hepatic Inflammation and Fibrosis in the NASH Rat Model via Targeting Hepatic Cell Death.罗沙维醇通过靶向肝脏细胞死亡改善 NASH 大鼠模型的肝脏炎症和纤维化。
Int J Mol Sci. 2022 Sep 5;23(17):10148. doi: 10.3390/ijms231710148.
8
Advances of microRNAs in regulating mitochondrial function: new potential application in NAFLD treatment.微小 RNA 在调控线粒体功能方面的研究进展:在非酒精性脂肪性肝病治疗中的新潜在应用。
Mol Biol Rep. 2022 Oct;49(10):9841-9853. doi: 10.1007/s11033-022-07503-0. Epub 2022 May 25.
9
Bioinformatics analysis reveals molecular connections between non-alcoholic fatty liver disease (NAFLD) and COVID-19.生物信息学分析揭示了非酒精性脂肪性肝病(NAFLD)与2019冠状病毒病(COVID-19)之间的分子联系。
J Cell Commun Signal. 2022 Dec;16(4):609-619. doi: 10.1007/s12079-022-00678-y. Epub 2022 May 7.
10
MicroRNA-200c coordinates HNF1 homeobox B and apolipoprotein O functions to modulate lipid homeostasis in alcoholic fatty liver disease.miRNA-200c 通过协调 HNF1 同源盒 B 和载脂蛋白 O 的功能来调节酒精性脂肪肝疾病中的脂质稳态。
J Biol Chem. 2022 Jun;298(6):101966. doi: 10.1016/j.jbc.2022.101966. Epub 2022 Apr 20.